Brent D G Page

Author PubWeight™ 9.39^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Orally bioavailable small-molecule inhibitor of transcription factor Stat3 regresses human breast and lung cancer xenografts.	Proc Natl Acad Sci U S A	2012	1.94
2	Disruption of transcriptionally active Stat3 dimers with non-phosphorylated, salicylic acid-based small molecules: potent in vitro and tumor cell activities.	Chembiochem	2009	1.20
3	Molecular disruption of oncogenic signal transducer and activator of transcription 3 (STAT3) protein.	Biochem Cell Biol	2009	1.09
4	Antagonism of the Stat3-Stat3 protein dimer with salicylic acid based small molecules.	ChemMedChem	2011	0.99
5	Altering pyridinone N-substituents to optimise activity as potential prodrugs for Alzheimer's disease.	Dalton Trans	2008	0.95
6	STAT3 activity is necessary and sufficient for the development of immune-mediated myocarditis in mice and promotes progression to dilated cardiomyopathy.	EMBO Mol Med	2013	0.85
7	Dynamic reprogramming of signaling upon met inhibition reveals a mechanism of drug resistance in gastric cancer.	Sci Signal	2014	0.85
8	An activatable multimodal/multifunctional nanoprobe for direct imaging of intracellular drug delivery.	Biomaterials	2011	0.83
9	3-Hydroxy-4-pyridinone derivatives as metal ion and amyloid binding agents.	Metallomics	2014	0.77